Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-01

NovoCure Ltd (NVCR)

CEO Frank Leonard was paid $6,975,329 in fiscal year 2025, ↑ up 19.8% from fiscal year 2024, the 8th percentile of its disclosed peer group (SEC filing 0001645113-26-000033 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$13,198,354
Ashley Cordova total, FY2025
Former Chief Executive Officer — highest-paid officer; CEO Frank Leonard: $6,975,329
8th
CEO (Frank Leonard) pay percentile vs peers
84:1
CEO-to-median pay ratio
91.04%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

NVCR's next annual pay disclosure, estimated April 19, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Ashley Cordova$901,837$0$8,249,965$2,752,814$811,653$0$482,085$13,198,354
Former Chief Executive Officer
Frank Leonard570,00004,999,9931,001,020389,644014,6726,975,329
Chief Executive Officer
Christoph Brackmann541,10201,999,9911,001,020324,6610296,6244,163,398
Chief Financial Officer
Uri Weinberg541,10201,999,9911,001,020270,5510347,2814,159,945
Chief Medical and Innovation Officer
Nicolas Leupin553,15101,999,9911,001,020276,5750168,3043,999,041
Former Chief Medical Officer
Michael Puri511,08901,999,9911,001,020255,5450166,2483,933,893
Chief Human Resources Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Ashley Cordova$13,198,354$6,091,704$6,317,066↑ +7,106,650
Frank Leonard6,975,3295,823,9305,039,237↑ +1,151,399
Christoph Brackmann4,163,398———
Uri Weinberg4,159,9455,055,906—↓ −895,961
Nicolas Leupin3,999,041———
Michael Puri3,933,893———

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read NovoCure Ltd's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper NVCR reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the NovoCure Ltd Peer Teardown Report

$13,198,354 Ashley Cordova total, FY2025

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of July 1, 2026 · Source: 0001645113-26-000033 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for NVCR

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
NVCRon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order NVCR

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against NVCR
6 companies name NVCR as a compensation peer

The list of companies that name NVCR as a peer is temporarily unavailable — recheck shortly.

Get the NovoCure Ltd Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Allyson OceanIndependent Director$437,044
Asaf DanzigerDirector$13,071,872
David HungIndependent Director$438,044
Jeryl HillemanIndependent Director$455,044
Kinyip Gabriel LeungIndependent Director$443,044
Kristin StaffordIndependent Director$440,044
Martin MaddenIndependent Director$455,047
Timothy ScannellIndependent Director$445,044
William DoyleChair of the Board$1,777,965
William VernonLead Independent Director$485,044
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
William VernonDirector2026-04-28D21,500$0$0Derivative, Class A CommonForm 4 ↗
William VernonDirector2026-04-28A21,50011244,885CommonForm 4 ↗
Kristin StaffordDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
David HungDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
William VernonDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
Jeryl HillemanDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
Timothy ScannellDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
Allyson OceanDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
Kinyip Gabriel LeungDirector2026-06-02D2,9451646,445Common, open-market saleForm 4 ↗
David HungDirector2026-06-03A11,61000CommonForm 4 ↗
Kristin StaffordDirector2026-06-03A11,61000CommonForm 4 ↗
Timothy ScannellDirector2026-06-03A11,61000CommonForm 4 ↗
William VernonDirector2026-06-03A11,61000CommonForm 4 ↗
Martin MaddenDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Martin MaddenDirector2026-06-03A11,61000CommonForm 4 ↗
David HungDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Jeryl HillemanDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Jeryl HillemanDirector2026-06-03A11,61000CommonForm 4 ↗
Allyson OceanDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Allyson OceanDirector2026-06-03A11,61000CommonForm 4 ↗
Kristin StaffordDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Kinyip Gabriel LeungDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Kinyip Gabriel LeungDirector2026-06-03A11,61000CommonForm 4 ↗
William VernonDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Timothy ScannellDirector2026-06-03A16,99900Derivative, Class A CommonForm 4 ↗
Frank LeonardChief Executive Officer2026-06-04D34,27318614,635Common, open-market saleForm 4 ↗
Asaf DanzigerDirector2026-06-30A268112,988CommonForm 4 ↗
Frank LeonardChief Executive Officer2026-06-30A1,9051121,241CommonForm 4 ↗
Michael PuriChief Human Resources Officer2026-06-30A1,9051121,241CommonForm 4 ↗
Arye Barak BenGeneral Counsel2026-06-30A1,2991114,484CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Uri WeinbergOPTION2025-03-04——81,499—$1,001,020
Frank LeonardRSU2025-06-04——179,426—3,000,003
Christoph BrackmannPSU2025-03-0427,48854,975—109,950999,995
Uri WeinbergPSU2025-03-0427,48854,975—109,950999,995
Michael PuriPSU2025-03-0427,48854,975—109,950999,995
Christoph BrackmannRSU2025-03-04——54,975—999,995
Nicolas LeupinRSU2025-03-04——54,975—999,995
Frank LeonardPSU2025-03-0427,48854,975—109,950999,995
Michael PuriRSU2025-03-04——54,975—999,995
Ashley CordovaPSU2025-03-04151,182302,363—604,7265,499,983
Uri WeinbergRSU2025-03-04——54,975—999,995
Frank LeonardRSU2025-03-04——54,975—999,995
Nicolas LeupinPSU2025-03-0427,48854,975—109,950999,995
Ashley CordovaRSU2025-03-04——151,181—2,749,982
Frank LeonardOPTION2025-03-04——81,499—1,001,020
Michael PuriOPTION2025-03-04——81,499—1,001,020
Ashley CordovaOPTION2025-03-04——224,123—2,752,814
Christoph BrackmannOPTION2025-03-04——81,499—1,001,020
Nicolas LeupinOPTION2025-03-04——81,499—1,001,020
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Uri Weinberg$999,995$999,995$1,001,02033.3%
Frank Leonard3,999,998999,9951,001,02016.7%
Christoph Brackmann999,995999,9951,001,02033.3%
Michael Puri999,995999,9951,001,02033.3%
Nicolas Leupin999,995999,9951,001,02033.3%
Ashley Cordova2,749,9825,499,9832,752,81450.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Michael PuriRSU54,975—$710,827
Frank LeonardOption117,26116.3—
Uri WeinbergRSU54,532—705,099
Frank LeonardRSU54,975—710,827
Nicolas LeupinRSU19,544—252,704
Frank LeonardPSU18,621—240,770
Ashley CordovaRSU151,181—1,954,770
Uri WeinbergPSU12,992—167,987
Ashley CordovaOption117,26116.3—
Frank LeonardOption2,90273.2—
Christoph BrackmannOption68,43016.59—
Ashley CordovaOption224,12318.19—
Ashley CordovaOption19,80676.97—
Uri WeinbergOption10,80376.97—
Uri WeinbergOption7,60580.59—
Ashley CordovaPSU302,363—3,909,554
Uri WeinbergPSU81,799—1,057,661
Frank LeonardRSU68,166—881,386
Michael PuriPSU54,975—710,827
Uri WeinbergRSU54,975—710,827
Christoph BrackmannRSU40,184—519,579
Michael PuriRSU28,802—372,410
Michael PuriRSU27,361—353,778
Ashley CordovaPSU23,818—307,967
Ashley CordovaRSU7,939—102,651
Uri WeinbergOption93,80816.3—
Frank LeonardOption15,48576.97—
Ashley CordovaOption9,41680.59—
Michael PuriOption81,49918.19—
Christoph BrackmannRSU54,975—710,827
Christoph BrackmannPSU54,975—710,827
Nicolas LeupinRSU54,975—710,827
Nicolas LeupinPSU54,975—710,827
Uri WeinbergPSU54,975—710,827
Christoph BrackmannOption81,49918.19—
Nicolas LeupinOption81,49918.19—
Uri WeinbergOption81,49918.19—
Frank LeonardPSU102,249—1,322,080
Ashley CordovaPSU102,249—1,322,080
Ashley CordovaRSU68,166—881,386
Frank LeonardPSU54,975—710,827
Frank LeonardOption81,49918.19—
Frank LeonardOption7,60580.59—
Frank LeonardRSU179,426—2,319,978
Frank LeonardRSU6,207—80,257
Uri WeinbergRSU4,330—55,987
05

Incentive-plan design — the Compensation Discussion & Analysis

Our executive compensation philosophy is to be reasonable and competitive with the market and our peers and pay for performance. The Committee strives to grant long term incentives at the upper end of the market and to deliver a meaningful portion of annual compensation in performance-based equity.

CEO STI target (% of salary)90%
CEO LTI target (% of salary)—
Independent consultantFrederic W. Cook & Co., Inc.
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-0375,392,1687,422,876137,55691.04%Passed
20252025-06-0480,626,4672,042,002263,40797.53%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-06-0391.04%a
20252025-06-0497.53%b

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted for the purposes of determining the number of votes cast and will accordingly have no effect on the outcome of this proposals.”.

b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will not be counted for the purposes of determining the number of votes cast and will accordingly have no effect on the outcome of this proposals.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)84 : 1
CEO total compensation$12,501,658
Median employee compensation$148,799
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Asaf DanzigerEmployee director$811,594$11,920,000——$340,278$13,071,872
William DoyleEmployee director · Board Chair907,500———870,4651,777,965
William VernonIndependent · Lead Independent Director · Audit · Compensation (Chair)110,000187,515187,52900485,044
Martin MaddenIndependent · Audit (Chair)80,000—375,04700455,047
Jeryl HillemanIndependent · Audit · Compensation80,000187,515187,52900455,044
Timothy ScannellIndependent · Audit70,000187,515187,52900445,044
Kinyip Gabriel LeungIndependent · Nominating and Corporate Governance (Chair)68,000187,515187,52900443,044
Kristin StaffordIndependent · Compensation65,000187,515187,52900440,044
David HungIndependent · Nominating and Corporate Governance63,000187,515187,52900438,044
Allyson OceanIndependent · Nominating and Corporate Governance62,000187,515187,52900437,044
Ashley CordovaEmployee director · Departed during FY000—00
Frank LeonardEmployee director · Newly elected000—00
09

Board fee structure and ownership guideline

Annual cash retainer—
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 13,000
Stock ownership guidelineNon-Employee Directors are expected to own Ordinary Shares of our Company having a value equal to at least three times the annual cash retainer.
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$2,317,094
Equity awards (grant-date value)$13,232,605
All other compensation$1,210,743
Total cost of the board$16,760,442

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies NovoCure Ltd names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including NovoCure Ltd.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Exelixis, Inc2025Michael Morrissey$1,306,040$30,539,552$0$1,382,591$33,239,183
2Incyte Corporation2025William Meury647,26027,509,6572,573,9981,300,00032,085,952
3Align Technology2025Joseph Hogan1,400,00016,556,87201,220,10019,193,988
4Insulet Corporation2025Ashley McEvoy729,80812,958,8502,999,9132,031,56218,858,968
5Exact Sciences Corporation2024Kevin Conroy1,083,36813,496,1380712,32915,539,378
6Alnylam Pharmaceuticals, Inc.2025Yvonne Greenstreet1,404,2005,512,5004,363,3803,562,50014,867,600
7Teladoc Health, Inc.2025Charles Divita, III800,0009,699,9960584,00011,202,996
8iRhythm Technologies2025Quentin Blackford700,0038,919,45701,350,00011,003,163
9Zai Lab Limited2025Samantha Du908,7303,233,7295,822,084695,17810,677,221
10Inspire Medical Systems, Inc.2025Timothy Herbert750,5725,999,6550961,5577,711,784
11CRISPR Therapeutics AG2025Samarth Kulkarni768,6223,474,9002,768,862659,0937,678,477
12NovoCure Ltd2025Frank Leonard570,0004,999,9931,001,020389,6446,975,329
1310x Genomics, Inc.2025Serge Saxonov674,2505,020,2690634,7256,329,244

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
NovoCure Ltd100%PSU 50 · RSU 25 · Options 25NoFrederic W. Cook & Co., Inc.
10x Genomics, Inc.93%PSU 60 · RSU 40Yes — 3-year Relative TSRAlpine Rewards LLC
Align Technology58.1%MSU 70 · RSU 30Yes — Relative Total Stockholder Return (TSR) vs. Nasdaq Composite IndexCompensia, Inc.
Alnylam Pharmaceuticals, Inc.200%PSU 50 · RSU 25 · Option 25NoPay Governance
CRISPR Therapeutics AGnot disclosednot disclosednot disclosedAlpine Rewards, LLC
Exact Sciences Corporation47%PSU 60 · RSU 40NoAon
Exelixis, Inc105%PSU 50 · RSU 50Yes — 2025 Relative TSR GoalAon
Incyte Corporation138.6%Performance Shares 60 · RSU 40Yes — relative total shareholder return (TSR)Aon
Inspire Medical Systems, Inc.111.4%PSU 50 · RSU 50NoAon
Insulet Corporation195.8%PSU 60 · RSU 20 · Options 20NoPearl Meyer & Partners, LLC
iRhythm Technologies173%RSU 50 · PSU 50Yes — Relative TSRAon and Mercer
Teladoc Health, Inc.73%RSU 50 · PSU 50NoAon
Zai Lab Limited85%Options 65 · RSU 20 · PSU 15NoPearl Meyer

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at NovoCure Ltd in fiscal 2025?
As disclosed, Ashley Cordova (Former Chief Executive Officer) was the highest-paid executive at NovoCure Ltd in fiscal 2025, with total compensation of $13,198,354.
How does NovoCure Ltd's chief executive pay compare to its disclosed peer group?
As disclosed, Frank Leonard's total compensation ranked at the 8th percentile of NovoCure Ltd's disclosed peer group.
What is NovoCure Ltd's CEO-to-median employee pay ratio?
As disclosed, NovoCure Ltd's CEO-to-median employee pay ratio was 84:1.
How did shareholders vote on NovoCure Ltd's executive compensation?
As disclosed, 91.04% of shareholders supported NovoCure Ltd's executive compensation in the latest say-on-pay vote.
How much does NovoCure Ltd spend in total on board compensation for fiscal 2025?
As disclosed, NovoCure Ltd reported total board compensation of $16,760,442 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Ashley CordovaDEF 14A2026-04-200001645113-26-000033Section “2025 Summary Compensation Table” · page 60. As printed: 13,198,354. Filing ↗machine: r6 · c48 · span 880842–880852
2Section 01, Frank LeonardDEF 14A2026-04-200001645113-26-000033Section “2025 Summary Compensation Table” · page 60. As printed: 6,975,329. Filing ↗machine: r2 · c48 · span 872221–872230
3Section 01, Christoph BrackmannDEF 14A2026-04-200001645113-26-000033Section “2025 Summary Compensation Table” · page 60. As printed: 4,163,398. Filing ↗machine: r10 · c48 · span 888907–888916
4Section 01, Uri WeinbergDEF 14A2026-04-200001645113-26-000033Section “2025 Summary Compensation Table” · page 60. As printed: 4,159,945. Filing ↗machine: r18 · c48 · span 901789–901798
5Section 01, Nicolas LeupinDEF 14A2026-04-200001645113-26-000033Section “2025 Summary Compensation Table” · page 60. As printed: 3,999,041. Filing ↗machine: r12 · c48 · span 892733–892742
6Section 01, Michael PuriDEF 14A2026-04-200001645113-26-000033Section “2025 Summary Compensation Table” · page 60. As printed: 3,933,893. Filing ↗machine: r15 · c48 · span 896870–896879
7Section 03, Uri Weinberg OPTIONDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r32 · c18 · span 993373–993379
8Section 03, Frank Leonard RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r7 · c16 · span 935271–935278
9Section 03, Christoph Brackmann PSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r18 · c16 · span 961223–961229
10Section 03, Uri Weinberg PSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r33 · c16 · span 995814–995820
11Section 03, Michael Puri PSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r28 · c16 · span 984311–984317
12Section 03, Christoph Brackmann RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r18 · c16 · span 961223–961229
13Section 03, Nicolas Leupin RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r23 · c16 · span 972739–972745
14Section 03, Frank Leonard PSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r5 · c16 · span 929947–929953
15Section 03, Michael Puri RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r28 · c16 · span 984311–984317
16Section 03, Ashley Cordova PSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t97 · r4 · c8 · span 479560–479567
17Section 03, Uri Weinberg RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r33 · c16 · span 995814–995820
18Section 03, Frank Leonard RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r5 · c16 · span 929947–929953
19Section 03, Nicolas Leupin PSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r23 · c16 · span 972739–972745
20Section 03, Ashley Cordova RSUDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t97 · r4 · c5 · span 479155–479162
21Section 03, Frank Leonard OPTIONDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r4 · c18 · span 927395–927401
22Section 03, Michael Puri OPTIONDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r27 · c18 · span 981870–981876
23Section 03, Ashley Cordova OPTIONDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t97 · r4 · c2 · span 478750–478757
24Section 03, Christoph Brackmann OPTIONDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r17 · c18 · span 958782–958788
25Section 03, Nicolas Leupin OPTIONDEF 14A2026-04-200001645113-26-000033Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t206 · r22 · c18 · span 970298–970304
26Section 07, pay ratioDEF 14A2026-04-200001645113-26-000033Section “CEO Pay Ratio”. As printed: 84 : 1. Filing ↗machine: span 1451642–1451644
27Section 08, Asaf DanzigerDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 13,071,872. Filing ↗machine: t147 · r3 · c14 · span 659119–659423
28Section 08, William DoyleDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 1,777,965. Filing ↗machine: t147 · r2 · c14 · span 656775–657107
29Section 08, William VernonDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 485,044. Filing ↗machine: t147 · r11 · c14 · span 676723–677024
30Section 08, Martin MaddenDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 455,047. Filing ↗machine: t147 · r7 · c14 · span 668187–668488
31Section 08, Jeryl HillemanDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 455,044. Filing ↗machine: t147 · r4 · c14 · span 661388–661689
32Section 08, Timothy ScannellDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 445,044. Filing ↗machine: t147 · r9 · c14 · span 672454–672755
33Section 08, Kinyip Gabriel LeungDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 443,044. Filing ↗machine: t147 · r6 · c14 · span 665922–666223
34Section 08, Kristin StaffordDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 440,044. Filing ↗machine: t147 · r10 · c13 · span 674328–674757
35Section 08, David HungDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 438,044. Filing ↗machine: t147 · r5 · c14 · span 663650–663951
36Section 08, Allyson OceanDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 437,044. Filing ↗machine: t147 · r8 · c13 · span 670058–670487
37Section 08, Ashley CordovaDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 0. Filing ↗
38Section 08, Frank LeonardDEF 14A2026-04-200001645113-26-000033Section “Director Compensation”. As printed: 0. Filing ↗
39Section 02, William Vernon 2026-04-28Form 42026-04-280001369091-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, William Vernon 2026-04-28Form 42026-04-280001369091-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Kristin Stafford 2026-06-02Form 42026-06-030001970438-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, David Hung 2026-06-02Form 42026-06-030001310880-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, William Vernon 2026-06-02Form 42026-06-030001369091-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Jeryl Hilleman 2026-06-02Form 42026-06-030001216628-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Timothy Scannell 2026-06-02Form 42026-06-030001451533-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Allyson Ocean 2026-06-02Form 42026-06-030001967326-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Kinyip Gabriel Leung 2026-06-02Form 42026-06-030001236183-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, David Hung 2026-06-03Form 42026-06-050001310880-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Kristin Stafford 2026-06-03Form 42026-06-050001970438-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Timothy Scannell 2026-06-03Form 42026-06-050001451533-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, William Vernon 2026-06-03Form 42026-06-050001369091-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Martin Madden 2026-06-03Form 42026-06-050001696864-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Martin Madden 2026-06-03Form 42026-06-050001696864-26-000001Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, David Hung 2026-06-03Form 42026-06-050001310880-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Jeryl Hilleman 2026-06-03Form 42026-06-050001216628-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Jeryl Hilleman 2026-06-03Form 42026-06-050001216628-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Allyson Ocean 2026-06-03Form 42026-06-050001967326-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Allyson Ocean 2026-06-03Form 42026-06-050001967326-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Kristin Stafford 2026-06-03Form 42026-06-050001970438-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Kinyip Gabriel Leung 2026-06-03Form 42026-06-050001236183-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Kinyip Gabriel Leung 2026-06-03Form 42026-06-050001236183-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, William Vernon 2026-06-03Form 42026-06-050001369091-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Timothy Scannell 2026-06-03Form 42026-06-050001451533-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Frank Leonard 2026-06-04Form 42026-06-050001822879-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Asaf Danziger 2026-06-30Form 42026-07-010001654435-26-000003Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Frank Leonard 2026-06-30Form 42026-07-010001822879-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Michael Puri 2026-06-30Form 42026-07-010001997032-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Arye Barak Ben 2026-06-30Form 42026-07-010001917165-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
69Section 06, 2026 voteForm 8-K2026-06-050001645113-26-000050Item 5.07 · say-on-pay result. As reported: 91.04% (votes for as printed: 75,392,168). Filing ↗
70Section 06, 2025 voteForm 8-K2025-06-060001645113-25-000011Item 5.07 · say-on-pay result. As reported: 97.53% (votes for as printed: 80,626,467). Filing ↗
71Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
72Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
73Section 09b board cost (computed)Computed——Cash 2,317,094 + equity 13,232,605 + all other 1,210,743 = 16,760,442, summed across the director compensation table rows.machine: formula: Σ = 16,760,442
74Exelixis, Inc, Section 10b CEO totalDEF 14A2026-04-150000939767-26-000046CEO total compensation as printed in Exelixis, Inc's own proxy. As printed: 33,239,183. Filing ↗machine: r2 · c10 · span 2655516–2655526
75Incyte Corporation, Section 10b CEO totalDEF 14A2026-04-280000879169-26-000031CEO total compensation as printed in Incyte Corporation's own proxy. As printed: 32,085,952. Filing ↗machine: t91 · r2 · c16 · span 637817–637827
76Align Technology, Section 10b CEO totalDEF 14A2026-04-070001097149-26-000023CEO total compensation as printed in Align Technology's own proxy. As printed: 19,193,988. Filing ↗machine: r2 · c42 · span 933168–933178
77Insulet Corporation, Section 10b CEO totalDEF 14A2026-04-060001140361-26-013333CEO total compensation as printed in Insulet Corporation's own proxy. As printed: 18,858,968. Filing ↗machine: t218 · r3 · c25 · span 1028076–1028087
78Exact Sciences Corporation, Section 10b CEO totalDEF 14A2025-04-290001124140-25-000034CEO total compensation as printed in Exact Sciences Corporation's own proxy. As printed: 15,539,378. Filing ↗machine: span 1077855–1077865
79Alnylam Pharmaceuticals, Inc., Section 10b CEO totalDEF 14A2026-04-060001628280-26-023923CEO total compensation as printed in Alnylam Pharmaceuticals, Inc.'s own proxy. As printed: 14,867,600. Filing ↗machine: span 1294691–1294701
80Teladoc Health, Inc., Section 10b CEO totalDEF 14A2026-04-070001477449-26-000020CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486
81iRhythm Technologies, Section 10b CEO totalDEF 14A2026-04-170001388658-26-000030CEO total compensation as printed in iRhythm Technologies's own proxy. As printed: 11,003,163. Filing ↗machine: r2 · c21 · span 1123498–1123508
82Zai Lab Limited, Section 10b CEO totalDEF 14A2026-04-280001704292-26-000030CEO total compensation as printed in Zai Lab Limited's own proxy. As printed: 10,677,221. Filing ↗machine: span 553414–553424
83Inspire Medical Systems, Inc., Section 10b CEO totalDEF 14A2026-03-200001140361-26-010490CEO total compensation as printed in Inspire Medical Systems, Inc.'s own proxy. As printed: 7,711,784. Filing ↗machine: r2 · c25 · span 1164868–1164877
84CRISPR Therapeutics AG, Section 10b CEO totalDEF 14A2026-04-210001193125-26-165158CEO total compensation as printed in CRISPR Therapeutics AG's own proxy. As printed: 7,678,477. Filing ↗machine: r2 · c25 · span 821649–821658
85NovoCure Ltd (subject), Section 10b CEO totalDEF 14A2026-04-200001645113-26-000033CEO total compensation as printed in NovoCure Ltd's own proxy. As printed: 6,975,329. Filing ↗machine: r2 · c48 · span 872221–872230
8610x Genomics, Inc., Section 10b CEO totalDEF 14A2026-04-240001628280-26-027201CEO total compensation as printed in 10x Genomics, Inc.'s own proxy. As printed: 6,329,244. Filing ↗machine: r3 · c48 · span 583283–583292
87Section 10a, Inspire Medical Systems, Inc. reciprocityDEF 14A—0001140361-26-010490Inspire Medical Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
88Section 10a, Insulet Corporation reciprocityDEF 14A—0001140361-26-013333Insulet Corporation names NovoCure Ltd in its own disclosed peer group (read from its most recent proxy). Filing ↗
89Section 10a, iRhythm Technologies reciprocityDEF 14A—0001388658-26-000030iRhythm Technologies's most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
90Section 10a, Teladoc Health, Inc. reciprocityDEF 14A—0001477449-26-000020Teladoc Health, Inc.'s most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
91Section 10a, Exelixis, Inc reciprocityDEF 14A—0000939767-26-000046Exelixis, Inc names NovoCure Ltd in its own disclosed peer group (read from its most recent proxy). Filing ↗
92Section 10a, Zai Lab Limited reciprocityDEF 14A—0001704292-26-000030Zai Lab Limited's most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
93Section 10a, Exact Sciences Corporation reciprocityDEF 14A—0001124140-25-000034Exact Sciences Corporation's most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
94Section 10a, Alnylam Pharmaceuticals, Inc. reciprocityDEF 14A—0001628280-26-023923Alnylam Pharmaceuticals, Inc.'s most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
95Section 10a, CRISPR Therapeutics AG reciprocityDEF 14A—0001193125-26-165158CRISPR Therapeutics AG's most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗
96Section 10a, 10x Genomics, Inc. reciprocityDEF 14A—0001628280-26-02720110x Genomics, Inc. names NovoCure Ltd in its own disclosed peer group (read from its most recent proxy). Filing ↗
97Section 10a, Align Technology reciprocityDEF 14A—0001097149-26-000023Align Technology's most recent proxy was read; its disclosed peer group does not include NovoCure Ltd. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the NovoCure Ltd Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
NVCR Peer Teardown Report